Xenetic Biosciences (XBIO) Financials

$2.38

$-0.09 (-3.64%)

As on 25-Sep-2026 13:16EDT

Market cap

$6 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	3.26	2.98	2.50	2.54	1.71	1.16
Cost of Revenue	--	--	--	--	0.03	0.04
Gross Profit	3.26	2.98	2.50	2.54	1.71	1.16
Operating Expenses	5.90	5.81	6.70	7.06	8.42	6.91
Operating Profit (EBIT)	-2.64	-2.83	-4.20	-4.52	-6.72	-5.75
Other Income	--	--	--	--	--	--
Profit before Tax	-2.48	-2.68	-3.96	-4.13	-6.55	-5.65
Provision for Tax	--	--	--	0.03	-0.17	-0.10
Profit after Tax (Net Income)	-2.48	-2.68	-3.96	-4.13	-6.55	-5.65
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-5.65

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	6.07	7.40	6.01	9.80	13.65	18.39
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	0.29	0.36
Current Liabilities	0.89	0.97	0.89	0.81	1.07	1.42
Total Liabilities	7.86	8.36	6.90	10.61	14.72	19.82

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.31	0.31	0.31	1.02	1.07	1.09
Current Assets	6.65	8.05	6.59	9.59	13.65	18.72
Total Assets	7.86	8.36	6.90	10.61	14.72	19.82
Total Debt*	--	--	--	--	--	0.03
Net Current Assets	5.76	7.08	5.69	8.78	12.58	17.30

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-2.29	-2.82	-4.11	-4.65	-4.74
Cash Flow from Investing Activities	--	--	--	--	-0.50	--
Cash from Financing Activities	--	4.00	0.00	0.00	1.29	11.45
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.19	-1.17	-2.57	-2.69	-4.32	-5.52
Cash EPS ($)	--	-1.17	-2.57	-2.69	-4.30	-5.49
Adjusted Book Value ($)	--	3.23	3.90	6.37	9.00	18.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.00	-1.83	-2.68	-3.06	-4.64
Free Cash Flow per Share ($)	--	-1.00	-1.83	-2.68	-3.39	-4.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-40.00	-50.12	-35.27	-40.86	-36.78
ROE (%)	-36.75	-40.00	-50.12	-35.27	-40.90	-36.88
ROA (%)	-35.06	-35.12	-45.24	-32.65	-37.95	-34.22
EBIT Margin (%)	-15.64	--	-158.39	-176.69	-383.87	-486.36
Net Margin (%)	-75.90	-90.07	-158.39	-162.78	-383.87	-486.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	33.30	0.19	-0.02	0.49	0.47	1.66
EBIT Growth (%)	54.05	--	11.75	31.51	-16.07	-20.25
Net Profit Growth (%)	19.72	32.31	4.22	36.90	-16.07	48.18
EPS Growth (%)	40.60	0.54	0.04	0.38	0.22	-3.43
Book Value Growth (%)	-8.28	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.85	-1.55	-1.28	-0.07	-0.23
Price / Book Value	0.95	0.67	1.02	0.54	0.03	0.07
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.03	1.09	0.00	0.89	1.94	3.01
Close Price ($)	2.91	2.17	3.99	3.45	2.85	12.90
High Price ($)	13.93	13.93	5.18	7.50	14.19	56.80
Low Price ($)	1.90	1.90	2.78	2.55	2.40	12.10
Market Cap ($ Cr)	6.49	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	0.00
Short term debt to equity ratio	--	--	--	--	--	0.00
Current Ratio	7.43	8.32	7.37	11.84	12.72	13.18
Quick Ratio	7.43	--	--	--	--	--
Interest Coverage	--	--	--	--	-39.58	-55.57

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.46	0.39	0.29	0.20	0.10	0.07
Receivable days	--	--	--	--	--	157.34
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	4,388.39	3,550.72
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.